The Incidence and Risk Factors of New-onset Type 2 Diabetes Mellitus After Gestational Diabetes Read more about The Incidence and Risk Factors of New-onset Type 2 Diabetes Mellitus After Gestational Diabetes
Aldosterone-renin ratio in screening for primary aldosteronism: clinical audit Read more about Aldosterone-renin ratio in screening for primary aldosteronism: clinical audit
Reduction in systolic blood pressure (SBP) with semaglutide treatment is not due to weight loss (WL) alone: data from SUSTAIN Read more about Reduction in systolic blood pressure (SBP) with semaglutide treatment is not due to weight loss (WL) alone: data from SUSTAIN
Referral rates of patients with diabetes to secondary care are determined by practice size and confidence in treatment, not by HbA1c level Read more about Referral rates of patients with diabetes to secondary care are determined by practice size and confidence in treatment, not by HbA1c level
Home Diabetic foot ulcer service: a safe and clinically effective model for managing patients with diabetic foot ulcers in the community Read more about Home Diabetic foot ulcer service: a safe and clinically effective model for managing patients with diabetic foot ulcers in the community
Driving improvements in inpatient diabetes care - keep your eye on the dashboard! Read more about Driving improvements in inpatient diabetes care - keep your eye on the dashboard!
Comparable glycaemic control and hypoglycaemia outcomes in adult patients with type 2 diabetes (T2D) initiating insulin glargine 300 U/mL (Gla-300) vs insulin degludec (IDeg) in real-world clinical practice: DELIVER Naïve D study Read more about Comparable glycaemic control and hypoglycaemia outcomes in adult patients with type 2 diabetes (T2D) initiating insulin glargine 300 U/mL (Gla-300) vs insulin degludec (IDeg) in real-world clinical practice: DELIVER Naïve D study
Similar variability of fasting and 24-h self-measured plasma glucose (SMPG) with insulin glargine 300 U/mL (Gla-300) vs insulin degludec 100 U/mL (IDeg-100) in insulin- naïve adults with T2DM: the randomised BRIGHT trial Read more about Similar variability of fasting and 24-h self-measured plasma glucose (SMPG) with insulin glargine 300 U/mL (Gla-300) vs insulin degludec 100 U/mL (IDeg-100) in insulin- naïve adults with T2DM: the randomised BRIGHT trial
Inpatient audit for recurrent DKA (Diabetic ketoacidocis) to highlight areas for service improvement in Warrington hospital Read more about Inpatient audit for recurrent DKA (Diabetic ketoacidocis) to highlight areas for service improvement in Warrington hospital
Achieving glycaemic control in patients with diabetes on hemodialysis Read more about Achieving glycaemic control in patients with diabetes on hemodialysis
